Glenmede Trust CO Na Catalent, Inc. Transaction History

Glenmede Trust CO Na

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 16, 2022	BUY	$72.36 - $113.1 $256,226 - $400,487	3,541 New	3,541 $256,000
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $16,918 - $20,755	-197 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $3,564 - $4,532	49 Added 33.11%	197 $16,000
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $3,265 - $5,374	-68 Reduced 31.48%	148 $10,000
Q4 2019 Feb 12, 2020	BUY	$47.06 - $56.64 $3,105 - $3,738	66 Added 44.0%	216 $12,000
Q2 2019 Aug 13, 2019	SELL	$39.26 - $54.21 $353 - $487	-9 Reduced 5.66%	150 $8,000
Q1 2019 May 14, 2019	SELL	$29.84 - $43.92 $1,909 - $2,810	-64 Reduced 28.7%	159 $6,000
Q4 2018 Feb 14, 2019	BUY	$29.95 - $46.34 $3,204 - $4,958	107 Added 92.24%	223 $6,000
Q2 2018 Aug 15, 2018	BUY	$38.72 - $42.52 $1,703 - $1,870	44 Added 61.11%	116 $5,000
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $2,430 - $3,000	72	72 $0

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.